Current Neuropharmacology
Volume 17, 12 Issues, 2019
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Ranking and Category
-
59th of 267 in
Neurosciences
-
33rd of 267 in
Pharmacology & Pharmacy
Contents
Current Neuropharmacology, Volume 14 - Number 7
Editorial
Review Article
Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression
, 14(7): 665 - 673Eunsoo Won and Yong-Ku Kim
DOI: 10.2174/1570159X14666151208113006
Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression
Review Article
Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
, 14(7): 674 - 687Frank M. Schmidt, Kenneth C. Kirkby and Nicole Lichtblau
DOI: 10.2174/1570159X14666160115130414
Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
Review Article
Animal Models of Maternal Immune Activation in Depression Research
, 14(7): 688 - 704Marianne Ronovsky, Stefanie Berger, Barbara Molz, Angelika Berger and Daniela D. Pollak
DOI: 10.2174/1570159X14666151215095359
Animal Models of Maternal Immune Activation in Depression Research
Review Article
A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders
, 14(7): 705 - 720Joanna Ślusarczyk, Ewa Trojan, Jakub Chwastek, Katarzyna Głombik and Agnieszka Basta-Kaim
DOI: 10.2174/1570159X14666160219131357
A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders
Review Article
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
, 14(7): 721 - 731Ji-chun Zhang, Wei Yao and Kenji Hashimoto
DOI: 10.2174/1570159X14666160119094646
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
Review Article
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
, 14(7): 732 - 742Ole Kohler, Jesper Krogh, Ole Mors and Michael Eriksen Benros
DOI: 10.2174/1570159X14666151208113700
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
Review Article
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem
, 14(7): 743 - 748Ekta Franscina Pinto and Chittaranjan Andrade
DOI: 10.2174/1570159X14666160106155129
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem
Review Article
Systems Genomics Support for Immune and Inflammation Hypothesis of Depression
, 14(7): 749 - 758Abhay Sharma
DOI: 10.2174/1570159X14666160106155331
Systems Genomics Support for Immune and Inflammation Hypothesis of Depression
Review Article
Gap Junction Blockers: An Overview of their Effects on Induced Seizures in Animal Models
, 14(7): 759 - 771Joaquín Manjarrez-Marmolejo and Javier Franco-Pérez
DOI: 10.2174/1570159X14666160603115942
Gap Junction Blockers: An Overview of their Effects on Induced Seizures in Animal Models
Review Article
Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol
, 14(7): 772 - 780Megan M. Eaton, Allison L. Germann, Ruby Arora, Lily Q. Cao, Xiaoyi Gao, Daniel J. Shin, Albert Wu, David C. Chiara, Jonathan B. Cohen, Joe Henry Steinbach, Alex S. Evers and Gustav Akk
DOI: 10.2174/1570159X14666160202121319
Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol
  |
Editor-in-Chief
T.E. Salt
University College London
Institute of Ophthalmology
London EC1V9EL
UK
Biography
View Full Editorial Board
University College London
Institute of Ophthalmology
London EC1V9EL
UK
Biography
Biography of T.E. Salt
Professor Tom Salt obtained his Degrees from The Universities of Cambridge and Bristol, is co-founder and Director of Neurexpert Ltd, and Emeritus Professor at University College London. He has worked in the pharmaceutical industry, and acted as a consultant and adviser to industry.
Professor Salt's research encompasses the pharmacology of neurotransmitters in relation to the sensory system systems, and more recently the functional consequences of neurodegeneration. He has published over 200 research and review papers, and is a member of several editorial boards and Editor in Chief of "Current Neuropharmacology"
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 with the assistance of Dr. T.E. Salt, who is the current Editor-in-Chief serving since 2003.
Scopus CiteScore Metrics: 3.02
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net